Summary & Overview
CPT 57065: Destruction of Large or Complex Vaginal Lesions
CPT code 57065 denotes the surgical destruction of one or more large or complex vaginal lesions. This code captures procedures where lesions are not straightforward or small, and it is used to document and bill for operative services addressing significant vaginal pathology. Accurate use of this code matters nationally because it affects surgical claims, provider reimbursement, and clinical reporting for gynecologic procedures involving lesion destruction.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of how CPT code 57065 is defined, typical sites of service, and which payers commonly adjudicate claims for this type of surgical procedure. The publication also covers benchmarks and policy considerations relevant to billing and coding for complex vaginal lesion destruction, clinical context for when the code is appropriate, and common modifiers and billing scenarios to be aware of.
This summary is intended for a national audience of health policy analysts, coding professionals, and provider billing staff who need a clear, practical reference on the clinical and administrative significance of CPT code 57065.
Billing Code Overview
CPT code 57065 describes a procedure in which the provider destroys one or more large or complex vaginal lesions. This procedure is a surgical/operative service directed at removal or destruction of abnormal tissue within the vagina.
-
Service type: Surgical destruction of vaginal lesion(s)
-
Typical site of service: Ambulatory surgical center or hospital operating room, with some procedures potentially performed in a procedure suite depending on clinical complexity and anesthesia needs.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 45-year-old woman referred to a gynecologic surgeon for one or more large or complex vaginal lesions causing bleeding, pain, or recurrent symptoms despite conservative therapy. After clinical evaluation including pelvic examination and, if indicated, colposcopy or directed biopsy to exclude malignancy, the patient is scheduled for operative destruction of vaginal lesion(s). The procedure is commonly performed in an ambulatory surgery center or hospital operating room under regional or general anesthesia; local anesthesia with sedation may be used for smaller lesions. The clinical workflow includes preoperative evaluation, informed consent, marking and mapping of lesion margins, application of destructive modality (e.g., laser ablation, electrosurgery, fulguration, or topical cytotoxic agents) to fully destroy lesion tissue, hemostasis, specimen submission if excision or biopsy portions are obtained, postprocedure recovery, and discharge with wound care and follow-up for surveillance and pathology review if applicable.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
59 | Distinct procedural service | Use when another distinct procedure or service is performed in a separate anatomic site or session and not normally bundled with the destruction procedure. |
62 |